A modified 4-strata risk assessment incorporating TAPSE/sPAP for pulmonary arterial hypertension: evidence from a large chinese real-world cohort
30 August 2026 (15:15 - 16:00)
Organised by: 

Abstract
About the speaker

Fuwai Hospital, Beijing (China)
6 More presentations in this session
Discordance between PAH risk scores in systemic sclerosis–associated pulmonary arterial hypertension
Doctor A. Cruz Utrilla (Madrid, ES)
Mrs I. Silfversparre (Gothenburg, SE)
Doctor Z. Xu (Shanghai, CN)
Access the full session
The Event
ESC Congress 2026
30 August 2026
15:15 CET
You may be interested in
Congress Presentation
Congress Presentation
Congress Presentation
Congress Presentation



